Axillary staging in breast cancer patients treated with neoadjuvant chemotherapy in two Dutch phase III studies

por Vriens, Birgit E.P., Keymeulen, Kristien B.M., Kroep, Judith R., Charehbili, Ayoub, Peer, Petronella G., de Boer, Maaike, Aarts, Maureen J.B., Heuts, Esther M., Tjan-Heijnen, Vivianne C.G.
Publicado 2017

Direct Medical Costs of Advanced Breast Cancer Treatment: A Real-World Study in the Southeast of The Netherlands

por Schneider, Paul Peter, Ramaekers, Bram L., Pouwels, Xavier, Geurts, Sandra, Ibragimova, Khava, de Boer, Maaike, Vriens, Birgit, van de Wouw, Yes, den Boer, Marien, Pepels, Manon, Tjan-Heijnen, Vivianne, Joore, Manuela
Publicado 2021

Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy

por Aarnoutse, Romy, Ziemons, Janine, Hillege, Lars E., de Vos-Geelen, Judith, de Boer, Maaike, Bisschop, Saskia M. P., Vriens, Birgit E. P. J., Vincent, Jeroen, van de Wouw, Agnes J., Le, Giang N., Venema, Koen, Rensen, Sander S., Penders, John, Smidt, Marjolein L.
Publicado 2022

The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2− advanced breast cancer patients: A study of the Dutch SONABRE Registry

por Meegdes, Marissa, Geurts, Sandra M. E., Erdkamp, Frans L. G., Dercksen, Marcus Wouter, Vriens, Birgit E. P. J., Aaldering, Kirsten N. A., Pepels, Manon J. A. E., van de Winkel, Linda M. H., Teeuwen, Nathalie J. A., de Boer, Maaike, Tjan‐Heijnen, Vivianne C. G.
Publicado 2021

Intestinal Microbiota in Postmenopausal Breast Cancer Patients and Controls

por Aarnoutse, Romy, Hillege, Lars E., Ziemons, Janine, De Vos-Geelen, Judith, de Boer, Maaike, Aerts, Elvira M. E. R., Vriens, Birgit E. P. J., van Riet, Yvonne, Vincent, Jeroen, van de Wouw, Agnes J., Le, Giang N., Venema, Koen, Rensen, Sander S., Penders, John, Smidt, Marjolein L.
Publicado 2021

Variability of cost trajectories over the last year of life in patients with advanced breast cancer in the Netherlands

por Schneider, Paul P., Pouwels, Xavier G. L. V., Passos, Valéria Lima, Ramaekers, Bram L. T., Geurts, Sandra M. E., Ibragimova, Khava I. E., de Boer, Maaike, Erdkamp, Frans, Vriens, Birgit E. P. J., van de Wouw, Agnes J., den Boer, Marien O., Pepels, Manon J., Tjan-Heijnen, Vivianne C. G., Joore, Manuela A.
Publicado 2020

Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry

por Ibragimova, Khava I. E., Geurts, Sandra M. E., Meegdes, Marissa, Erdkamp, Frans, Heijns, Joan B., Tol, Jolien, Vriens, Birgit E. P. J., Dercksen, Marcus W., Aaldering, Kirsten N. A., Pepels, Manon J. A. E., van de Winkel, Linda, Peters, Natascha A. J. B., Teeuwen-Dedroog, Nathalie J. A., Vriens, Ingeborg J. H., Tjan-Heijnen, Vivianne C. G.
Publicado 2023

Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry

por Ibragimova, Khava I. E., Geurts, Sandra M. E., Croes, Sander, Erdkamp, Frans, Heijns, Joan B., Tol, Jolien, Vriens, Birgit E. P. J., Aaldering, Kirsten N. A., Dercksen, Marcus W., Pepels, Manon J. A. E., Peters, Natascha A. J. B., van de Winkel, Linda, Tilli, Dominique J. P., Vriens, Ingeborg J. H., de Boer, Maaike, Tjan-Heijnen, Vivianne C. G.
Publicado 2021

Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry

por Meegdes, Marissa, Geurts, Sandra M.E., Erdkamp, Frans L.G., Dercksen, M. Wouter, Vriens, Birgit E.P.J., Aaldering, Kirsten N.A., Pepels, Manon J.A.E., van de Winkel, Linda M.H., Peters, Natascha A.J.B., Tol, Jolien, Heijns, Joan B., van de Wouw, Agnes J., de Fallois, Aude J.O., van Kats, Maartje A.C.E., Tjan-Heijnen, Vivianne C.G.
Publicado 2023

Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial...

por de Groot, Stefanie, Pijl, Hanno, Charehbili, Ayoub, van de Ven, Saskia, Smit, Vincent T. H. B. M., Meershoek-Klein Kranenbarg, Elma, Heijns, Joan B., van Warmerdam, Laurence J. C., Kessels, Lonneke W., Dercksen, M. Wouter, Pepels, Manon J. A. E., van Laarhoven, Hanneke W. M., Vriens, Birgit E. P. J., Putter, Hein, Fiocco, Marta, Liefers, Gerrit-Jan, van der Hoeven, Jacobus J. M., Nortier, Johan W. R., Kroep, Judith R.
Publicado 2019

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry

por Meegdes, Marissa, Ibragimova, Khava I. E., Lobbezoo, Dorien J. A., Vriens, Ingeborg J. H., Kooreman, Loes F. S., Erdkamp, Frans L. G., Dercksen, M. Wouter, Vriens, Birgit E. P. J., Aaldering, Kirsten N. A., Pepels, Manon J. A. E., van de Winkel, Linda M. H., Tol, Jolien, Heijns, Joan B., van de Wouw, Agnes J., Peters, Natascha A. J. B., Hochstenbach-Waelen, Ananda, Smidt, Marjolein L., Geurts, Sandra M. E., Tjan-Heijnen, Vivianne C. G.
Publicado 2022

Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience

por Vriens, Ingeborg J. H., ter Welle-Butalid, Elena M., de Boer, Maaike, de Die-Smulders, Christine E. M., Derhaag, Josien G., Geurts, Sandra M. E., van Hellemond, Irene E. G., Luiten, Ernest J. T., Dercksen, M. Wouter, Lemaire, Bea M. D., van Haaren, Els R. M., Vriens, Birgit E. P. J., van de Wouw, Agnes J., van Riel, Anne-marie M. G. H., Janssen-Engelen, Sandra L. E., van de Poel, Marlène H. W., Schepers-van der Sterren, Ester E. M., van Golde, Ron J. T., Tjan-Heijnen, Vivianne C. G.
Publicado 2020